Home | Publications | Diagnostics place holder
place holder place holder

Diagnostics

The Decentralized Diagnostic Testing Markets Business Challenges And Marketing Strategies


Publication Date   January 2008
Publisher   Venture Planning Group
Product Type   Strategic Report
Pages   not applicable
ISBN Number   not applicable
Product Code   VPG001
Ask a question about this product?

Price £9,830.00

approximately: $19,468 | €12,495

Summary


The Decentralized Diagnostic Testing Markets report helps current suppliers, as well as companies planning to diversify into decentralized testing markets, to evaluate emerging opportunities in these dynamic and increasingly competitive market segments, and to assist decision-makers in developing effective business, R&D and marketing strategies. The survey provides a comprehensive analysis of ten market segments, including their size and growth through 2016, future market requirements, emerging technologies and products, profile major competitors and anticipated market entrants, and propose specific business expansion strategies for instrument and consumable suppliers. This two-volume, 900-page report contains 252 tables and presents market segmentation analysis; sales and market share estimates; review of technologies and current and emerging products; competitive assessments; and strategic recommendations.

Content


  • The Decentralization Phenomenon
    • The Study Will Analyze The Major Economic, Technological, Demographic, Regulatory, and Social Driving Forces, along with Their Impact on The Decentralization Phenomenon through 2016.
  • Major Decentralized/Poc Testing Market Segments
    • The following Decentralized/Poc Testing Market Segments Will Be Surveyed:
      • Ambulatory Care Centers
      • Ancillary Hospital Locations
        • - Emergency Departments
        • - Intensive Care Units
        • - Operating Suites
      • Birth Centers
      • Cancer Clinics
      • Home/Self Testing
      • Nursing Homes
      • Physician Offices/Group Practices.(This Market Will Be Further Segmented by Physician Specialty, Practice Composition and Size )
      • Surgery Centers, and Others
      • Routine and Special Chemistry
      • Microbiology/Infectious Diseases
      • Hematology
      • Flow Cytometry
      • Tumor Markers
      • Coagulation
      • Immunoproteins
      • Tdm
      • Drugs of Abuse
      • Endocrine Function
      • Urinalysis
  • Test Categories
    • The Study Will Provide 10-Year Test Volume and Sales Forecasts for The following Assay Categories:
  • Market Size and Growth
    • The 10-Year Estimates and Projections for Each Decentralized Market Segment Will Be Provided for:
      • Test Volume, Including Number of Tests Ordered and Performed in-House.
      • Instrument Placements and Installed Base, by Manufacturer and Model.
      • Instrument and Reagent Sales.
  • Market Share Analysis
    • The Study Will Provide Sales and Market Share Estimates for Major Suppliers of Decentralized Testing Instruments and Reagents.
  • Technological Assessment
    • A Detailed Analysis of The following Technologies and Their Market Applications Will Be Provided:
  • Future Regulatory Environment
    • Current Status and Likely Changes in Government Regulations Will Be Explored, Including The following Issues:
      • Reimbursement
      • Certification and Licensing
      • Diagnostic Efficacy
      • Labeling Requirements
      • Performance Standards
      • Pre-Market Testing, and Others
      • Biosensors
      • Monoclonal and Polyclonal Antibodies
      • Biosensors
      • Immunoassays
      • Immunoassays
      • Dna Probes
      • Biochips
      • It, and Others
  • Business Opportunities & Strategic Recommendations
      • Emerging Business and New Product Opportunities.
      • Alternative Marketing Tactics.
      • Potential Market Entry Barriers and Concerns.
      • Strategic Planning Issues and Concerns.
  • Methodology Interviews
    • The Study Will Be Based on Interviews with Major Suppliers, and Individuals from Selected Hospitals and Medical Research Centers.
  • Industry Shows
    • The Information from Relevant Industry Shows, Marketing Conferences and Scientific Symposia Occurring during The Course of This Project Will Be Included in The Report.
  • Secondary Information Sources
    • An Exhaustive Search of Technical and Business Literature Will Be Conducted, Including Manufacturer Product and Financial Literature, Trade Association Surveys, Financial Analyst Reports and General Periodicals.
  • Venture Planning Group'S Data Files
    • Vpg's Proprietary Database Contains Current Information on Diagnostics Markets, Technologies, Companies, and Products, and Was Developed in The Course of over 100 Syndicated Studies and Numerous Single-Client Assignments.
  • Data Analysis
    • The Data Gathered from Both Primary and Secondary Information Sources Will Be Evaluated and Organized into Concise Tables.
    • The Final Report Will Be Comprehensive, with Emphasis on Product Development and Marketing Strategies Capable of Being Implemented.
    • Subscribers Will Receive Complimentary Copies of The Previous Edition While The New Report Is in Preparation.
      • Abaxis
      • Abbott
      • Adeza Biomedical
      • Alfa Wassermann
      • Bayer Diagnostics
      • Beckman Coulter
      • Becton Dickinson
      • Bio-Chem Tech Lab
      • Biosite Diagnostics
      • C R. Bard
      • Chematics
      • Chronimed
      • Compucyte
      • Dade Behring
      • DexCom
      • Fuji Photo Film
      • Gds Technology
      • Glucon
      • Hemagen Diagnostics
      • Hemocue
      • Home Diagnostics
      • Horiban
      • Hypoguard
      • i-Stat
      • Immucor
      • Orion
      • Therasense
      • Inagellan
      • Pathology
      • Worldwide
      • Instrumentation Laboratory
      • Provalis Medical, and Others
      • International Biomedical
      • Quidel
      • Iris
      • Response Biomedical
      • J&J
      • Roche
      • Konica
      • Shimadzu
      • Menarini
      • Spectral Diagnostics
      • NewPro Technology
      • Stanbio Laboratory
      • Nova Biomedical
      • Strategic Diagnostics
  • Innovative Marketing Strategies
    • The Reprt Will Explore Innovative Promotion and Distribution Strategies, as Well as Pros and Cons of Using Direct Sales Force Versus Distributors and Dealers.
  • Market Needs and Challenges
    • The Study Will Identify The Major Opportunities Emerging in The Decentralized Testing Markets during The next 10-Years, and Propose NoneIdealNone Product Models with Tentative Operating Characteristics and Prices.
  • Market Participants
    • The Major Suppliers and Potential Market Entrants Will Be Profiled, Including Their Sales, Product Portfolios, Technological Know-How, New Decentralized Products in R & D, Collaborative Arrangements and Marketing Strategies.
  • Partial List of Tables
    • following Is a Partial List of Tables from Section V: U S A.
    • A Complete List of All 252 Tables Is Available on Request.
  • Summary Tables
    • Summary Table I: Total Sales Forecasts by Market
    • Summary Table Ii: Reagent Sales Forecasts by Market
    • Summary Table Iii: Instrument Sales Forecasts by Market
  • List of Tables
    • Table Iv-1: Major Suppliers of Albumin Tests
    • Table Iv-2: Major Suppliers of Alkaline Phosphatase Tests
    • Table Iv-3: Major Suppliers of Alt/Sgpt Tests
    • Table Iv-4: Major Suppliers of Amylase Tests
    • Table Iv-5: Major Suppliers of Ast/Sgot Tests
    • Table Iv-6: Major Suppliers of Bilirubin Tests
    • Table Iv-7: Major Suppliers of Blood Gas Analyzers
    • Table Iv-8: Major Suppliers of Bun Tests
    • Table Iv-9: Major Suppliers of Calcium Tests
    • Table Iv-10: Major Suppliers of Cholesterol Tests
    • Table Iv-11: Major Suppliers of Creatinine Tests
    • Table Iv-12: Major Suppliers of Electrolyte Tests
    • Table Iv-13: Major Suppliers of Ferritin Tests
    • Table Iv-14: Major Suppliers of Ggt Tests
    • Table Iv-15: Major Suppliers of Glucose Tests
    • Table Iv-16: Major Suppliers of Hdl Tests
    • Table Iv-17: Major Suppliers of Iron Tests
    • Table Iv-18: Major Suppliers of Ldh Tests
    • Table Iv-19: Major Suppliers of Magnesium Tests
    • Table Iv-20: Major Suppliers of Phosphorus Tests
    • Table Iv-21: Major Suppliers of Protein Tests
    • Table Iv-22: Major Suppliers of Triglycerides Tests
    • Table Iv-23: Major Suppliers of Uric Acid Tests
    • Table Iv-24: Major Suppliers of Vitamin B-12/Folate Tests
    • Table Iv-25: Major Suppliers of Aids Tests
    • Table Iv-26: Major Suppliers of Campylobacter Tests
    • Table Iv-27: Major Suppliers of Helicobacter Pylori Tests
    • Table Iv-28: Major Suppliers of Herpes Tests
    • Table Iv-29: Major Suppliers of Influenza Tests
    • Table Iv-30: Major Suppliers of Legionella Tests
    • Table Iv-31: Major Suppliers of Lyme Disease Tests
    • Table Iv-32: Major Suppliers of Measles Tests
    • Table Iv-33: Major Suppliers of Meningitis Tests
    • Table Iv-34: Major Suppliers of Mononucleosis Tests
    • Table Iv-35: Major Suppliers of Mumps Tests
    • Table Iv-36: Major Suppliers of Mycoplasma Tests
    • Table Iv-37: Major Suppliers of Papilloma Virus Tests
    • Table Iv-38: Major Suppliers of Pneumonia Tests
    • Table Iv-39: Major Suppliers of Rsv Tests
    • Table Iv-40: Major Suppliers of Ra Tests
    • Table Iv-41: Major Suppliers of Rotavirus Tests
    • Table Iv-42: Major Suppliers of Rubella Tests
    • Table Iv-43: Major Suppliers of Salmonella Tests
    • Table Iv-44: Major Suppliers of Shigella Tests
    • Table Iv-45: Major Suppliers of Streptococci Tests
    • Table Iv-46: Major Suppliers of Syphilis Tests
    • Table Iv-47: Major Suppliers of Tdm Tests
    • Table Iv-48: Major Suppliers of Digoxin Tests
    • Table Iv-49: Major Suppliers of Lithium Tests
    • Table Iv-50: Major Suppliers of Phenytoin/Dilantin Tests
    • Table Iv-51: Major Suppliers of Theophylline Tests
    • Table Iv-52: Major Suppliers of Valproic Acid Tests
    • Table Iv-53: Major Suppliers of Fsh Tests
    • Table Iv-54: Major Suppliers of Hcg Tests
    • Table Iv-55: Major Suppliers of Lh Tests
    • Table Iv-56: Major Suppliers of Prolactin Tests
    • Table Iv-57: Major Suppliers of T3 Tests
    • Table Iv-58: Major Suppliers of T4 Tests
    • Table Iv-59: Major Suppliers of Tsh Tests
    • Table Iv-60: Major Suppliers of Afp Tests
    • Table Iv-61: Major Suppliers of Cea Tests
    • Table Iv-62: Major Suppliers of Occult Blood Tests
    • Table Iv-63: Major Suppliers of Pap Tests
    • Table Iv-64: Major Suppliers of Psa Tests
    • Table Iv-65: Major Suppliers of Aptt Tests
    • Table Iv-66: Major Suppliers of Alpha-2 Antiplasmin Tests
    • Table Iv-67: Major Suppliers of at Iii Tests
    • Table Iv-68: Major Suppliers of Bleeding Time Tests
    • Table Iv-69: Major Suppliers of D-Dimer Tests
    • Table Iv-70: Major Suppliers of Fdp Tests
    • Table Iv-71: Major Suppliers of Heparin Tests
    • Table Iv-72: Major Suppliers of Protein C Tests
    • Table Iv-73: Major Suppliers of Protein S Tests
    • Table Iv-74: Major Suppliers of Pt Tests
    • Table Iv-75: Major Suppliers of Thrombin Time Tests
    • Table Iv-76: Major Suppliers of Crp Tests
    • Table Iv-77: Major Suppliers of Abused Drug Tests
    • Table Iv-78: Hematology Analyzers Feature Comparison
    • Table Iv-79 : Major Suppliers of Biosensors
    • Table V- 1: Home Testing Sales Forecasts by Market
    • Table V- 2: Pol Total Sales Forecasts by Market
    • Table V- 3: Pol Reagent Sales Forecasts by Market
    • Table V- 4: Pol Instrument Sales Forecasts by Market
    • Table V- 5: Office Physician Forecasts by Practice Type
    • Table V- 6: Office Physicians Forecasts by Speciality
    • Table V- 7: Physician Office Forecasts by Practices Type
    • Table V- 8: Pol by Practice Size
    • Table V- 9: Pol Chemistry Test Volume Forecasts
    • Table V-10: Pol Profile and Individual Test Forecasts
    • Table V-11: Pol Infectious Disease Test Volume Forecasts
    • Table V-12: Pol Microbiology Test Volume Forecasts
    • Table V-13: Pol Hematology Test Volume Forecasts
    • Table V-14: Pol Flow Cytometry Test Volume Forecasts
    • Table V-15: Pol Coagulation Test Volume Forecasts
    • Table V-16: Pol Tdm Test Volume Forecasts
    • Table V-17: Pol Endocrine Function Test Volume Forecasts
    • Table V-18: Pol Tumor Marker Test Volume Forecasts
    • Table V-20: Pol Immunoprotein Test Volume Forecasts
    • Table V-21: Pol Abused Drug Test Volume Forecasts
    • Table V-22: Pol Chemistry Test Forecasts by Practice Type
    • Table V-23: Pol Microbiology Test Forecasts by Practice Type
    • Table V-24: Pol Hematology Test Forecasts by Practice Type
    • Table V-25: Pol Coagulation Test Forecasts by Practice Type
    • Table V-26: Pol Tdm Test Forecasts by Practice Type
    • Table V-27: Pol Endocrine Function Test Forecasts by Practice Type
    • Table V-28: Pol Tumor Marker Test Volume Forecasts by Practice Type
    • Table V-29: Pol Immunoproteins Test Forecasts by Practice Type
    • Table V-30: Pol Abused Drug Test Forecasts by Practice Type
    • Table V-31: Pol Chemistry Reagent Sales Forecasts by Test
    • Table V-32: Pol Infectious Disease Reagent Sales Forecasts by Test
    • Table V-33: Pol Microbiology Reagent Sales Forecasts by Market
    • Table V-34: Pol Hematology Sales Forecasts by Test
    • Table V-35: Pol Tdm Sales Forecasts by Test
    • Table V-36: Pol Endocrine Function Sales Forecasts by Test
    • Table V-37: Pol Tumor Marker Sales Forecasts by Test
    • Table V-38: Pol Coagulation Sales Forecasts
    • Table V-39: Pol Immunoprotein Sales Forecasts by Test
    • Table V-40: Pol Abused Drug Sales Forecasts by Test
    • Table V-41: Ancillary Hospital Locations Forecasts
    • Table V-42: Ancillary Hospital Locations Annual Utilization
    • Table V-43: Er Total Diagnostics Sales Forecasts by Market
    • Table V-44: Er Reagent Sales Forecasts by Market
    • Table V-45: Er Instrument Sales Forecasts by Market
    • Table V-46: Er Chemistry Test Volume Forecasts
    • Table V-47: Er Chemistry Profile and Individual Test Volume Forecasts
    • Table V-48: Er Abused Drug Test Volume Forecasts
    • Table V-49: Er Hematology Test Volume Forecasts
    • Table V-50: Er Coagulation Test Volume Forecasts
    • Table V-51: Er Infectious Disease Test Volume Forecasts
    • Table V-52: Er Chemistry Sales Forecasts by Test
    • Table V-53: Er Abused Drug Sales Forecasts by Test
    • Table V-54: Er Hematology Sales Forecasts
    • Table V-55: Er Coagulation Sales Forecasts
    • Table V-56: Er Infectious Disease Sales Forecasts by Test
    • Table V-57: Or Total Diagnostics Sales Forecasts by Market
    • Table V-58: Or Reagent Sales Forecasts by Market
    • Table V-59: Or Instrument Sales Forecasts by Market
    • Table V-60: Or Chemistry Test Volume Forecasts
    • Table V-61: Or Hematology Test Volume Forecasts
    • Table V-62: Or Coagulation Test Volume Forecasts
    • Table V-63: Or Chemistry Sales Forecasts by Test
    • Table V-64: Or Hematology Sales Forecasts
    • Table V-65: Or Coagulation Sales Forecasts
    • Table V-66: Icu/Ccu Total Diagnostics Sales Forecasts by Market
    • Table V-67: Icu/Ccu Reagent Sales Forecasts by Market
    • Table V-68: Icu/Ccu Instrument Sales Forecasts by Market
    • Table V-69: Icu/Ccu Chemistry Test Volume Forecasts
    • Table V-70: Icu/Ccu Hematology Test Volume Forecasts
    • Table V-71: Icu/Ccu Coagulation Test Volume Forecasts
    • Table V-72: Icu/Ccu Chemistry Sales Forecasts by Test
    • Table V-73: Icu/Ccu Hematology Sales Forecasts
    • Table V-74: Icu/Ccu Coagulation Sales Forecasts
    • Table V-75: Cancer Clinics Total Diagnostics Sales Forecasts by Market
    • Table V-76: Cancer Clinics Reagent Sales Forecasts by Market
    • Table V-77: Cancer Clinics Instrument Sales Forecasts by Market
    • Table V-78: Cancer Clinics Tumor Marker Test Volume Forecasts
    • Table V-79: Cancer Clinics Chemistry Test Volume Forecasts
    • Table V-80: Cancer Clinics Hematology Test Volume Forecasts
    • Table V-81: Cancer Clinics Endocrine Test Volume Forecasts
    • Table V-82: Cancer Clinics Coagulation Test Volume Forecasts
    • Table V-83: Cancer Clinics Tumor Marker Sales Forecasts by Test
    • Table V-84: Cancer Clinics Chemistry Sales Forecasts by Test
    • Table V-85: Cancer Clinics Hematology Sales Forecasts
    • Table V-86: Cancer Clinics Endocrine Function Sales Forecasts
    • Table V-87: Cancer Clinics Coagulation Sales Forecasts
    • Table V-88: Acc Total Diagnostics Sales Forecasts by Market
    • Table V-89: Acc Reagent Sales Forecasts by Market
    • Table V-90: Acc Instrument Sales Forecasts by Market
    • Table V-91: Acc Facilities and Patient Visit Forecasts
    • Table V-92: Acc Most Frequent Diagnoses
    • Table V-93: Acc Chemistry Test Volume Forecasts
    • Table V-94: Acc Hematology Test Volume Forecasts
    • Table V-95: Acc Microbiology Test Volume Forecasts
    • Table V-96: Acc Abused Drug Test Volume Forecasts
    • Table V-97: Acc Coagulation Test Volume Forecasts
    • Table V-98: Acc Chemistry Sales Forecasts by Test
    • Table V-99: Acc Abused Drug Sales Forecasts by Test
    • Table V-100: Acc Hematology Sales Forecasts
    • Table V-101: Acc Microbiology Sales Forecasts by Test
    • Table V-102: Acc Coagulation Sales Forecasts
    • Table V-103: Surgery Centers Total Diagnostics Sales Forecasts by Market
    • Table V-104: Surgery Centers Reagent Sales Forecasts by Market
    • Table V-105: Surgery Centers Instrument Sales Forecasts by Market
    • Table V-106: Surgery Centers Facility and Procedure Forecasts
    • Table V-107: Surgery Centers Most Frequently Performed Procedures
    • Table V-108: Surgery Centers Chemistry Test Volume Forecasts
    • Table V-109: Surgery Centers Hematology Test Volume Forecasts
    • Table V-110: Surgery Centers Coagulation Test Volume Forecasts
    • Table V-111: Surgery Centers Microbiology Test Volume Forecasts
    • Table V-112: Surgery Centers Chemistry Sales Forecasts by Test
    • Table V-113: Surgery Centers Hematology Sales Forecasts
    • Table V-114: Surgery Centers Microbiology Sales Forecasts by Test
    • Table V-115: Surgery Centers Coagulation Sales Forecasts
    • Table V-116: Nursing Homes Total Diagnostics Sales Forecasts by Market
    • Table V-117: Nursing Homes Reagent Sales Forecasts by Market
    • Table V-118: Nursing Homes Instrument Sales Forecasts by Market
    • Table V-119: Nursing Homes Facility, Bed and Occupancy Rate Forecasts
    • Table V-120: Nursing Homes Chemistry Test Volume Forecasts
    • Table V-121: Nursing Homes Coagulation Test Volume Forecasts
    • Table V-122: Nursing Homes Hematology Test Volume Forecasts
    • Table V-123: Nursing Homes Chemistry Sales Forecasts by Test
    • Table V-124: Nursing Homes Coagulation Sales Forecasts
    • Table V-125: Nursing Homes Hematology Sales Forecasts
    • Table V-126: Birth Centers Total Diagnostics Sales Forecasts by Market
    • Table V-127: Birth Centers Reagent Sales Forecasts by Market
    • Table V-128: Birth Centers Instrument Sales Forecasts by Market
    • Table V-129: Birth Centers Facility, Patient Visit, and Birth Rate Forecasts
    • Table V-130: Birth Centers Chemistry Test Volume Forecasts
    • Table V-131: Birth Centers Profile and Individual Test Volume Forecasts
    • Table V-132: Birth Centers Microbiology Test Volume Forecasts
    • Table V-133: Birth Centers Coagulation Test Volume Forecasts
    • Table V-134: Birth Centers Hematology Test Volume Forecasts
    • Table V-135: Birth Centers Chemistry Sales Forecasts by Test
    • Table V-136: Birth Centers Microbiology Sales Forecasts
    • Table V-137: Birth Centers Hematology Sales Forecasts
    • Table V-138: Birth Centers Coagulation Sales Forecasts
    • Table V-139: Major Suppliers Sales and Market Shares